Antibiotic resistance is a global public health threat. Modern health systems rely on antibiotics to prevent and treat infections, and the need for new drugs is urgent.
China approves AstraZeneca-Sanofi’s RSV antibody for infants
Share this article The RSV prevention therapy will be made available for infants for the 2024-2025 RSV season. Credit: Inara Prusakova / Shutterstock.com. The Chinese